4//SEC Filing
Kaufmann Gunnar F. 4
Accession 0001209191-23-036994
CIK 0001260990other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:00 PM ET
Size
6.7 KB
Accession
0001209191-23-036994
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2023-06-12$0.35/sh+25,000$8,745→ 91,726 total - Purchase
Common Stock
2023-06-14$0.36/sh+3,000$1,079→ 94,726 total
Footnotes (1)
- [F1]The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.3448 to $0.3500. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:00 PM ET
- Size
- 6.7 KB